Neurogenetic Disorders tests in Dubai & UAE

Compare available Neurogenetic Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

750.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurogenetic Disorders test prices

Showing 16–25 of 25 matching tests.

Neurogenetic Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4668 LRPPRC Gene Sequencing (Leigh Syndrome, French-Canadian Type) Test This test evaluates the LRPPRC gene for pathogenic variants associated with Leigh syndrome, French-Canadian type.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LRPPRC gene", "Deletion/duplication analysis of the LRPPRC gene"] Parameters [] Preparation [] Indications ["Diagnosis of Leigh syndrome, French-Canadian type", "Familial genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G31.82 Clinical summary This test evaluates the LRPPRC gene for pathogenic variants associated with Leigh syndrome, French-Canadian type.
TEST-4631 NDUFAF2 Gene Leigh Syndrome Genetic Test This test evaluates the NDUFAF2 gene for pathogenic variants associated with Leigh syndrome.	Blood (EDTA) or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NDUFAF2 gene sequence", "Pathogenic variants (point mutations, small insertions/deletions, copy number changes)"] Parameters [] Preparation ["Clinical history and pedigree counselling mandatory"] Indications ["Suspected Leigh syndrome", "Family history of Leigh syndrome", "Neurological symptoms consistent with mitochondrial disorder"] Measurement technique Confirm with laboratory Codes LOINC: 95213-9 ICD-10: G31.82 Clinical summary This test evaluates the NDUFAF2 gene for pathogenic variants associated with Leigh syndrome.
TEST-4250 SLC2A1 Gene (DYT18) Genetic Test This test identifies pathogenic variants in the SLC2A1 gene associated with GLUT1 deficiency syndrome.	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC2A1 gene", "Presence of mutations causing GLUT1 deficiency"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed medications unless advised otherwise by physician"] Indications ["Suspected GLUT1 deficiency syndrome", "Evaluation of dystonia, seizures, and developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 21633-4 ICD-10: E74.8 Clinical summary This test identifies pathogenic variants in the SLC2A1 gene associated with GLUT1 deficiency syndrome.
TEST-3105 Spinocerebellar Ataxia Type 7 (SCA7) ATXN7 Gene Mutation Test This test detects pathogenic CAG trinucleotide repeat expansions in the ATXN7 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 7.	Whole blood	5 working days (Sample by Tuesday 11 am → Report Saturday)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion length in the ATXN7 gene"] Parameters [{"name": "CAG Repeat Length", "reference_range": "4–17 repeats (Wild-type)"}] Preparation [] Indications ["Symptomatic individuals suspected of having Spinocerebellar Ataxia Type 7", "Differential diagnosis of progressive ataxia", "Assessment of hereditary risk for family members"] Measurement technique Confirm with laboratory Codes LOINC: 78000-9 ICD-10: G11.8, Z13.71, Z84.8 Clinical summary This test detects pathogenic CAG trinucleotide repeat expansions in the ATXN7 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 7.
TEST-5906 TDP1 Gene (SCAN1) Spinocerebellar Ataxia with Axonal Neuropathy Genetic Test This genetic test evaluates the TDP1 gene for pathogenic variants associated with Spinocerebellar Ataxia with Axonal Neuropathy (SCAN1).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TDP1 gene", "DNA repair enzyme function"] Parameters [] Preparation ["No fasting required", "No medication adjustments required"] Indications ["Suspected diagnosis of SCAN1", "Family history of SCAN1", "Genetic counseling for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 77785-2 ICD-10: G11.1 Clinical summary This genetic test evaluates the TDP1 gene for pathogenic variants associated with Spinocerebellar Ataxia with Axonal Neuropathy (SCAN1).
TEST-5543 TIMM8A Gene Opticoacoustic Nerve Atrophy with Dementia Genetic Test This test analyzes the TIMM8A gene for mutations associated with Mohr-Tranebjaerg syndrome.	Peripheral Blood or Buccal Swab	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the TIMM8A gene", "Copy Number Variations (CNVs) within the TIMM8A gene"] Parameters [] Preparation ["No specific fasting required", "Inform the phlebotomist of any medications you are taking"] Indications ["Clinical suspicion of Mohr-Tranebjaerg syndrome", "Family history of Mohr-Tranebjaerg syndrome", "Genetic counseling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81323-0 ICD-10: G31.89 Clinical summary This test analyzes the TIMM8A gene for mutations associated with Mohr-Tranebjaerg syndrome.
TEST-5899 TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test This test evaluates the TPP1 gene for pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 7 (SCAR7).	Peripheral Whole Blood or Buccal Swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TPP1 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any recent blood transfusions (within 21 days)."] Indications ["Individuals with clinical features suggestive of SCAR7", "Family history of SCAR7", "Genetic counselling for families with SCAR7"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G11.2 Clinical summary This test evaluates the TPP1 gene for pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 7 (SCAR7).
TEST-5503 VPS53 Gene Pontocerebellar Hypoplasia Type 2E Genetic Test This genetic test analyzes the VPS53 gene to detect pathogenic variants associated with Pontocerebellar Hypoplasia Type 2E (PCH2E).	Peripheral Whole Blood	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS53 gene coding region", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Definitive diagnosis of PCH2E", "Carrier screening", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 98936-4 ICD-10: Q04.8 Clinical summary This genetic test analyzes the VPS53 gene to detect pathogenic variants associated with Pontocerebellar Hypoplasia Type 2E (PCH2E).
TEST-4582 WNK1 Gene HSAN2A Genetic Test This genetic test detects pathogenic variants in the WNK1 gene associated with hereditary sensory and autonomic neuropathy type IIA (HSAN2A).	Whole blood (EDTA), extracted DNA, or FTA card (blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WNK1 gene pathogenic variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No fasting required", "No special preparation required"] Indications ["Suspected HSAN2A based on clinical presentation", "Family history suggestive of autosomal recessive inheritance", "Carrier screening for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 55989-0 ICD-10: G60.8 Clinical summary This genetic test detects pathogenic variants in the WNK1 gene associated with hereditary sensory and autonomic neuropathy type IIA (HSAN2A).
TEST-4944 ZNF41 Gene Mental Retardation, X-linked Type 89 Genetic Test This test analyzes the ZNF41 gene to identify pathogenic variants associated with X-linked intellectual disability type 89.	Peripheral Whole Blood (3-5 mL EDTA tube) or FTA Card Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ZNF41 gene", "Coding regions and splice sites of ZNF41"] Parameters [] Preparation ["Do not discontinue prescribed antiepileptic, neuroleptic, or behavioral medication unless directed by a physician."] Indications ["Diagnosis of X-linked intellectual disability type 89 (XLID89)", "Family history of XLID89", "Genetic counseling for recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: F79 Clinical summary This test analyzes the ZNF41 gene to identify pathogenic variants associated with X-linked intellectual disability type 89.

Category overview

Neurogenetic Disorders: overview

Understanding the broader hereditary factors affecting your central and peripheral nervous systems empowers you to manage chronic, overlapping symptoms and make highly informed health decisions. Representing an expansive offering within our advanced Genetics services, testing for Neurogenetic Disorders utilizes comprehensive multi-gene panels to evaluate the complex pathways linked to hereditary spastic paraplegias, leukodystrophies, and familial seizure disorders. Utilizing cutting-edge genomic technology, this robust screening delivers the definitive clarity needed to diagnose complex neurological cases, safely guiding highly customized neurology oversight, proactive physical rehabilitation, and specialized genetic counseling. Consistently ranked among the top diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic precision, and prompt, reliable reporting. Prioritize your lifelong neurological wellness—book your neurogenetic disorders testing in UAE, arrange a secure clinical sample transfer, or reach out to our dedicated medical genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.